Loading...
NPI 1083698534 · Itasca, IL · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Laboratory Corporation Of America is a clinical medical laboratory provider located in Itasca, Illinois. This profile covers 100 Medicare and 127 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Laboratory Corporation Of America |
| Address | 150 Spring Lake Dr |
| City | Itasca |
| State | IL |
| ZIP | 60143 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | November 29, 2005 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $4.4M |
| Medicaid | $3.4M |
LABORATORY CORPORATION OF AMERICA is listed under the Clinical Medical Laboratory taxonomy and its Medicare and Medicaid claims mix is concentrated in diagnostic chemistry and urine/metabolic analyses, plus stone composition testing; high-volume codes include 82507, 82140, 83945 and 82365, and the presence of panel codes such as 80053 and 80061 indicates it performs both single analyte and panel testing for routine and specialty metabolic work. The code descriptions point to an operation focused on large-scale specimen processing (urine electrolytes, oxalate, citrate, creatinine) and specialized infectious or immunologic assays (e.g., 86480 on the Medicaid side).
Medicare revenue is $4.4M and is materially concentrated: the precomputed top-three Medicare codes account for 38.8% of this provider's total Medicare revenue, driven by 82507 (19.1% of Medicare revenue, $796.5K), 82140 (9.9%, $411.5K) and 83945 (9.8%, $411.3K). This concentration signals that a small set of high-volume lab assays underpin a large share of Medicare receipts.
On the Medicaid side the provider has $3.4M in revenue and an even higher concentration: the precomputed top-three Medicaid codes make up 50.6% of total Medicaid revenue, led by 86480 (35.0%, $937.5K), followed by 82507 (10.4%, $279K) and 82140 (5.2%, $139.3K). That Medicaid mix underscores a dominant contribution from the TB-related interferon assay (86480) plus the same high-volume metabolic/urine tests seen in Medicare.
Payer mix shows Medicare is the larger single payer for this entity ($4.4M Medicare vs $3.4M Medicaid) but both payers are substantial, so operational and contract decisions should account for sizable exposure to both programs. The similar code overlap across payers (notably 82507 and 82140 appearing in the top lists for both Medicare and Medicaid) suggests the same service lines are monetized across payer types rather than one payer driving a distinct service set.
This provider is a dominant national volume outlier on several specific Medicare codes: 82507, 82140 and 83945 each rank #1 nationally and are labeled in the data as "extreme outlier" and at the 100th percentile, indicating volumes far above typical national providers for those tests. A number of other Medicare CPTs (for example 84105, 82340, 82436 and several more) also rank #1 nationally or sit at the 100th percentile, reinforcing that this entity is a national leader for a cluster of urine/metabolic assays.
Competitive standing in Medicaid is also strong for specific assays: 86480 ranks #2 of 117 in-state at the 99th percentile (labeled "typical, unremarkable" volume relative to its rank), while many urine/electrolyte codes (for example 82507, 82340, 84105, 84300) rank at or near the top in-state (multiple codes rank #2 in-state and several are in the 90+ percentiles). These rankings imply significant in-state market share for the same testing suite that drives Medicare volume.
The billing profile mixes very high-volume, low-paid-per-claim tests and some higher-paid assays: numerous Medicare codes show tens of thousands of claims with low average paid/claim (for example multiple ~29K–30K claim line items with $4–$7 avg paid/claim), while Medicaid shows large revenue from 86480 at $47 avg paid/claim. This pattern is consistent with a centralized reference-laboratory model that scales volume to generate revenue rather than relying on high per-claim reimbursement.
This NPI has long tenure in the dataset, enumerated on 2005-11-29 (~21 years ago), indicating an established presence in Medicare/Medicaid billing. Given the long tenure plus the concentration and national/state ranking profile, analysts should treat this entity as a stable, high-volume laboratory operator whose financial exposure is concentrated in a handful of high-volume assays across both payers.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
100 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 82507 | The lab analyst measures the amount of citrate in a patient specimen. Citrate is the conjugate base of citric acid. | 29,500 | $30 | $796.5K |
| 82140 | The lab analyst performs a measurement of the ammonia in the blood, plasma, or other body fluids. Elevated levels of ammonia in the blood are frequently indicative of an infectious process. | 29,390 | $10 | $411.5K |
| 83945 | The lab analyst measures the oxalate level, commonly in a 24 hour urine specimen. Oxalate is a substance commonly present in certain vegetables and nuts. Oxalate is also present in normal urine… | 29,380 | $10 | $411.3K |
| 83735 | The lab analyst performs a test to measure the amount of magnesium in a patient specimen. | 30,250 | $10 | $211.8K |
| 84105 | The lab analyst performs a test to evaluate the level of phosphate, which is phosphorus not contained in biological compounds, in a patient urine specimen. | 29,500 | $10 | $177K |
| 82340 | The lab analyst performs the technical lab test to analyze the quantitative value of calcium in the timed urine specimen. | 29,500 | $10 | $177K |
| 82436 | The lab analyst measures the amount of chloride in the urine specimen. Chloride is an important ion needed for electrolyte balance. | 29,380 | $10 | $176.3K |
| 82570 | The lab analyst measures the amount of creatinine, in a patient specimen, other than blood. Creatinine is the waste material generated by the muscle tissue produced from the breakdown of creatine… | 29,950 | $10 | $149.8K |
| 84300 | The lab analyst performs a test to measure the concentration of sodium in urine, in either a random specimen or a specimen collected over 24 hours. | 29,500 | $10 | $147.5K |
| 84540 | The lab analyst performs a test to measure the amount of urea nitrogen in patient urine. | 29,490 | $10 | $147.5K |
Showing 1–10 of 100
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 100 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
100 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 82507 | 1 | 10 | 22,650 | $30 | $477.2K |
| 83945 | 1 | 10 | 22,600 | $10 | $247.9K |
| 82615 | 1 | 10 | 11,070 | $10 | $103.6K |
| 84105 | 1 | 10 | 22,650 | $10 | $98.7K |
| 82436 | 1 | 10 | 22,580 | $10 | $97.6K |
| 84540 | 1 | 10 | 22,660 | $10 | $94.8K |
| 84392 | 1 | 10 | 22,590 | $10 | $93.4K |
| 84560 | 1 | 10 | 22,600 | $1 | $86.6K |
| 84133 | 1 | 10 | 22,600 | $1 | $80.8K |
| 82340 | 1 | 10 | 11,670 | $10 | $78.1K |
Showing 1–10 of 100
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
127 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 86480 | The lab analyst performs a test to evaluate a cell mediated immunity gamma interferon antigen response to certain tuberculosis, or TB, antibodies. | 19,950 | $50 | $937.5K |
| 82507 | The lab analyst measures the amount of citrate in a patient specimen. Citrate is the conjugate base of citric acid. | 23,250 | $10 | $279K |
| 82140 | The lab analyst performs a measurement of the ammonia in the blood, plasma, or other body fluids. Elevated levels of ammonia in the blood are frequently indicative of an infectious process. | 23,220 | $10 | $139.3K |
| 83945 | The lab analyst measures the oxalate level, commonly in a 24 hour urine specimen. Oxalate is a substance commonly present in certain vegetables and nuts. Oxalate is also present in normal urine… | 23,200 | $10 | $139.2K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 10,910 | $10 | $87.2K |
| 87086 | Culture, bacterial; quantitative, colony count, urine. | 11,040 | $10 | $77.3K |
| 83735 | The lab analyst performs a test to measure the amount of magnesium in a patient specimen. | 23,750 | $1 | $71.2K |
| 82340 | The lab analyst performs the technical lab test to analyze the quantitative value of calcium in the timed urine specimen. | 23,450 | $1 | $70.4K |
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 670 | $100 | $63.8K |
| 87651 | The lab analyst performs a test for the bacteria Streptococcus, group A, using amplified nucleic acid probe technique. Strep A commonly causes acute pharyngitis, or strep throat. | 1,930 | $30 | $63.6K |
Showing 1–10 of 127
How this provider's Medicaid billing volume and revenue compare to other Illinois providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Illinois median
127 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 82507 | The lab analyst measures the amount of citrate in a patient specimen. Citrate is the conjugate base of citric acid. | 2 | 10 | 53,650 | $10 | $735.8K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 207 | 350 | 400 | $70 | $514.7K |
| 83945 | The lab analyst measures the oxalate level, commonly in a 24 hour urine specimen. Oxalate is a substance commonly present in certain vegetables and nuts. Oxalate is also present in normal urine… | 2 | 10 | 23,200 | $10 | $245K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 127 | 210 | 680 | $20 | $206.4K |
| 87389 | The lab analyst performs a test to screen for human immunodeficiency virus, called HIV. The test screens for antigens of the HIV 1 virus and antibodies to the HIV 1 and HIV 2 viruses using an… | 115 | 250 | 450 | $40 | $185.7K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 252 | 360 | 600 | $30 | $165.1K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 268 | 360 | 630 | $30 | $165K |
| 87661 | The lab analyst performs a test for Trichomonas vaginalis using nucleic acid amplified probe technique. | 145 | 160 | 300 | $20 | $145.2K |
| 82615 | The lab analyst tests for the presence of the amino acids cystine and homocystine in a urine specimen; neither substance is normally present in the urine. Cystinuria is an inherited defect and can… | 2 | 10 | 30,820 | $1 | $133.8K |
| 84392 | The lab analyst performs a test to measure sulfate in patient urine, typically in a specimen collected for a 24 hour period. | 2 | 10 | 53,240 | $1 | $131.7K |
Showing 1–10 of 127
Other providers in the same ZIP code as Laboratory Corporation Of America, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Option Care Enterprises, Inc. | IL | Home Infusion Therapy Pharmacy | $0 | $45.6M |
| Litholink Corporation | IL | Clinical Medical Laboratory | $2.8M | $5.5M |
| Ophthalmology Surgery Center Of Illinois, LLC | IL | Ambulatory Surgical Clinic/Center | $1.7M | $0 |
| Ashish Bhatia | IL | Procedural Dermatology Physician | $618.5K | $0 |
| Marie Schlund | IL | Foot & Ankle Surgery Podiatrist | $189.6K | $14.9K |
| Paul Nelson | IL | Physical Therapist | $158.5K | $0 |
| Joseph Daw | IL | Plastic and Reconstructive Surgery Physician | $53.9K | $0 |
| Wendy Biela | IL | Certified Registered Nurse Anesthetist | $5.3K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.